Vimarsana
Biggest News Aggregation in the World

Page 12 - Jay Bradner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jay Bradner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jay Bradner Today - Breaking & Trending Today

Drug Discovery Is About to Get Faster. Thank AI. - Vimarsana News

Drug Discovery Is About to Get Faster. Thank AI.

Middle-East Arab News and Opinion - Asharq Al-Awsat is the world’s premier pan-Arab daily newspaper, printed simultaneously each day on four continents in 14 cities

Source: aawsat.com
What If Scientists Shared Their Reagents for Free? - Vimarsana News

What If Scientists Shared Their Reagents for Free?

Some researchers have decided to provide their products without financial compensation or expectations of authorship on resulting papers, prompting a flurry of new work.

Precision, Novartis ink Potential $1.4B Development Deal | North Carolina Biotechnology Center - Vimarsana News

Precision, Novartis ink Potential $1.4B Development Deal | North Carolina Biotechnology Center

Durham-based Precision Biosciences’ genome editing technology has drawn interest – and investment – from another global pharmaceutical giant. This time it’s Novartis.

Novartis, Voyager Therapeutics reach license option agreement for next-generation gene therapy vectors for neurological diseases - Vimarsana News

Novartis, Voyager Therapeutics reach license option agreement for next-generation gene therapy vectors for neurological diseases

Novartis gains target-specific access to next-generation AAV capsids that could be used for three diseases of the central nervous system, with options for two additional targets  

Gene team supports therapies for previously untreatable brain regions - Vimarsana News

Gene team supports therapies for previously untreatable brain regions

Novartis and Voyager Therapeutics announce partnership to develop gene therapies for neurological disorders - News - PharmaTimes